Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

An unexpected relapse has columnist Ahna Crum contemplating what remains when the miracle of stem cell transplant seems ...

The first person with multiple sclerosis was imaged in a clinical trial of a PET tracer to track myelin changes.

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate ...

Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

Columnist Ben Hofmeister sometimes misuses the word "we." It usually means he wants to feel included in something.

Desiree Lama is a 20-something-year-old PhD student living in Austin, Texas. She was diagnosed with relapsing-remitting multiple sclerosis during high school at only 17 years old but began ...